{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T01:52:26Z","timestamp":1777945946057,"version":"3.51.4"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hypercholesterolemia is a well-described risk factor for atherosclerotic cardiovascular disease. Statins remain the cornerstone of therapy. Statin intolerance (SI) particularly statin associated muscle symptoms (SAMS) and inappropriate stopping of treatment is associated with increased cardiovascular risk. A significant proportion of reported SAMS relates to expectation of side effects and can be termed the \u2018negative drucebo effect\u2019. Patients should be educated about SI, the negative drucebo effect, in addition to the benefits of adherence to the therapy when first prescribed a statin. The aim of this commentary is to discuss the issue of SI, the negative drucebo effect and to suggest some interventions that may be used to address this issue.<\/jats:p>","DOI":"10.1093\/qjmed\/hcae144","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T07:57:21Z","timestamp":1721980641000},"page":"143-145","source":"Crossref","is-referenced-by-count":2,"title":["Statin intolerance and the drucebo effect"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1187-2197","authenticated-orcid":false,"given":"B","family":"Mugawar","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Trinity College Dublin School of Medicine, Trinity Centre for Health Sciences, St James's Hospital , Dublin,","place":["Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1748-4593","authenticated-orcid":false,"given":"S","family":"Mcerlean","sequence":"additional","affiliation":[{"name":"Department of General Practice, Health Sciences Centre, University College Dublin School of Medicine , Dublin,","place":["Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"O\u2019 Connor","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Trinity College Dublin School of Medicine, Trinity Centre for Health Sciences, St James's Hospital , Dublin,","place":["Ireland"]},{"name":"Department of Pharmacology, St James\u2019s Hospital , Dublin,","place":["Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2577-0242","authenticated-orcid":false,"given":"C","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, St James\u2019s Hospital , Dublin,","place":["Ireland"]},{"name":"HRB Clinical Research Facility, St James\u2019s Hospital, Trinity College Dublin , Dublin,","place":["Ireland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,7,27]]},"reference":[{"key":"2025050509364369700_hcae144-B1","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwad125.269","article-title":"Restarting statins in a specialist lipid clinic setting","volume":"30","author":"Malone","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"2025050509364369700_hcae144-B2","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/jcsm.12960","article-title":"Step-by-step diagnosis and management of the nocebo\/drucebo effect in statin-associated muscle symptoms patients: a position paper from the international lipid expert panel (ILEP)","volume":"13","author":"Penson","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2025050509364369700_hcae144-B3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"2025050509364369700_hcae144-B4","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.2174\/138161211798220891","article-title":"Statin discontinuation in high-risk patients: a systematic review of the evidence","volume":"17","author":"Gomez Sandoval","year":"2011","journal-title":"Curr Pharm Des"},{"key":"2025050509364369700_hcae144-B5","doi-asserted-by":"crossref","first-page":"oeac071","DOI":"10.1093\/ehjopen\/oeac071","article-title":"Adherence to statin therapy: it seems we know everything, yet we do nothing","volume":"2","author":"Banach","year":"2022","journal-title":"Eur Heart J Open"},{"key":"2025050509364369700_hcae144-B6","doi-asserted-by":"crossref","first-page":"oeac070","DOI":"10.1093\/ehjopen\/oeac070","article-title":"Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs","volume":"2","author":"Engebretsen","year":"2022","journal-title":"Eur Heart J Open"},{"key":"2025050509364369700_hcae144-B7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/17460441.2019.1615436","article-title":"Can we further optimize statin therapy to increase tolerability?","volume":"14","author":"Ruscica","year":"2019","journal-title":"Expert Opin Drug Discov"},{"key":"2025050509364369700_hcae144-B8","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/eurheartj\/ehac015","article-title":"Prevalence of statin intolerance: a meta-analysis","volume":"43","author":"Byty\u00e7i","year":"2022","journal-title":"Eur Heart J"},{"key":"2025050509364369700_hcae144-B9","doi-asserted-by":"crossref","first-page":"n1537","DOI":"10.1136\/bmj.n1537","article-title":"Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses","volume":"374","author":"Cai","year":"2021","journal-title":"BMJ"},{"key":"2025050509364369700_hcae144-B10","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0140-6736(22)01545-8","article-title":"Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials","volume":"400","author":"Reith","year":"2022","journal-title":"Lancet"},{"key":"2025050509364369700_hcae144-B11","doi-asserted-by":"crossref","first-page":"n135","DOI":"10.1136\/bmj.n135","article-title":"Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials","volume":"372","author":"Herrett","year":"2021","journal-title":"BMJ"},{"key":"2025050509364369700_hcae144-B12","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jacc.2021.07.022","article-title":"Side effect patterns in a crossover trial of statin, placebo, and no treatment","volume":"78","author":"Howard","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"2025050509364369700_hcae144-B13","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.jacc.2024.03.388","article-title":"A Technology-Assisted web application for consumer access to a nonprescription statin medication","volume":"83","author":"Nissen","journal-title":"J Am Coll Cardiol"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/qjmed\/advance-article-pdf\/doi\/10.1093\/qjmed\/hcae144\/58695179\/hcae144.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/118\/3\/143\/58695179\/hcae144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/118\/3\/143\/58695179\/hcae144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T13:36:51Z","timestamp":1746452211000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/118\/3\/143\/7721939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,27]]},"references-count":13,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,7,27]]},"published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcae144","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,7,27]]}}}